CacheBy
Thermo Fisher Scientific H5N1 VN04-2 Monoclonal Antibody (15A3)
원본

Thermo Fisher Scientific H5N1 VN04-2 Monoclonal Antibody (15A3)

상품 한눈에 보기

H5N1 인플루엔자 A 바이러스 HA 단백질을 인식하는 단클론 항체. Western blot, IHC, ELISA, IP에 사용 가능. 다양한 H5N1 클레이드에 반응하며 교차 반응 없음. 액상 형태로 -20°C 보관, 연구용 전용.

판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
ADBIX 2026 전시회10/28~30 코엑스 · 사전등록 안내자세히보기
Thermo Fisher Scientific 500-301-975 H5N1 VN04-2 Monoclonal Antibody (15A3) 100 ul pk판매 단위 pk
재고 확인 필요
683,300원VAT 포함 751,630원

Thermo Fisher Scientific · Thermo Fisher Scientific H5N1 VN04-2 Monoclonal Antibody (15A3)

Applications

Application Tested Dilution
Western Blot (WB) Assay-dependent
Immunohistochemistry (IHC) Assay-dependent
ELISA 1:5,000
Immunoprecipitation (IP) Assay-dependent

Product Specifications

항목 내용
Species Reactivity Virus
Host / Isotype Mouse / IgG2a, kappa
Class Monoclonal
Type Antibody
Clone 15A3
Immunogen Concentrated purified virus preparation containing hemagglutinin (HA) protein of influenza A virus [strain A/Vietnam/1203/04 (H5N1)]
Conjugate Unconjugated
Form Liquid
Concentration Not determined
Storage Buffer Ascites
Contains 0.01% sodium azide
Storage Conditions -20°C, Avoid Freeze/Thaw Cycles
Shipping Conditions Ambient (domestic); Wet ice (international)

Product Specific Information

Store vial at -20°C prior to opening. Aliquot contents and freeze at -20°C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4°C as an undiluted liquid. Dilute only prior to immediate use.

This product was clarified from mouse ascitic fluid and is specific for H5 hemagglutinin (HA) protein of influenza A virus [strain A/Vietnam/1203/04 (H5N1)]. VN04-2 monoclonal antibody did not cross-react with influenza viruses of other HA subtypes. This monoclonal antibody reacted with H5N1 influenza virus representatives of different clades and subclades of the H5 HA subtype.

Target Information

Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic.

Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication.

The genetic make-up of the swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0개

아직 등록된 문의가 없어요.